3Suppliers
0Customers
2Debt Items
9Related Chains
Inhibrx Biosciences, Inc. Suppliers
| Ticker | Name | Confidence | Evidence |
|---|
| THIRD-PARTY-CDMOS |
THIRD-PARTY-CDMOS |
90%
|
The Company’s usage of third-party CDMOs for clinical and development efforts. |
| THIRD-PARTY-CROS |
THIRD-PARTY-CROS |
90%
|
The Company’s usage of third-party CROs for management of clinical trials. |
| THIRD-PARTIES |
THIRD-PARTIES |
85%
|
The Company’s usage of third-parties for other research and development efforts. |
Inhibrx Biosciences, Inc. Customers
No clients on recordNo downstream customers found in our database for Inhibrx Biosciences, Inc..
Inhibrx Biosciences, Inc. Debt Obligations
| Instrument | Description | Confidence | Evidence |
|---|
| INBX-DEBT |
Debt stack $180.9M |
90%
|
Market cache reports total debt of $180.9M. |
| INBX-DEBT-10273 |
Warrants outstanding: 0.0001 |
90%
|
xbrl warrant detail from xbrl 2025-12-31. |
Inhibrx Biosciences, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Inhibrx Biosciences, Inc..
Inhibrx Biosciences, Inc. Ownership
| Holder | Name | Confidence | Evidence |
|---|
| INBX-OWNER-PERCEPTIVE-ADVISORS-LLC |
PERCEPTIVE ADVISORS LLC |
90%
|
13F overlay lists PERCEPTIVE ADVISORS LLC as top holder; 140 tracked holders. |
Inhibrx Biosciences, Inc. Extended Supply Chain Network
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|
| AZN |
AstraZeneca PLC |
100.00 |
2 |
|
| JNJ |
Johnson & Johnson |
100.00 |
2 |
|
| PLRX |
Pliant Therapeutics, Inc. |
100.00 |
2 |
|
| BNTX |
BioNTech SE |
100.00 |
2 |
|
| GSK |
GSK plc |
100.00 |
2 |
|
| GNMSF |
Genmab A/S |
100.00 |
2 |
|
| PYXS |
Pyxis Oncology, Inc. |
100.00 |
2 |
|
| BIOCON |
BIOCON |
50.00 |
2 |
|
| BCAX |
Bicara Therapeutics Inc. |
36.29 |
1 |
['spend'] |
